Wockhardt posts ₹107 crore profit, antibiotic business drives turnaround
Wockhardt returned to profit in the June quarter of FY27, reporting a net profit of ₹107 crore against a loss of ₹108 crore a year earlier. Revenue rose 26 per cent to…
All posts tagged in Wockhardt
2Articles
Wockhardt gets USFDA nod for novel drug Zaynich
Wockhardt has received US Food and Drug Administration approval for Zaynich, a novel drug discovered and developed in-house, marking a first for an Indian pharmaceutical company. The company spent nearly Rs 6,800…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.